Ibuprofen and skin and soft tissue superinfections in children with varicella

P W Choo1, J G Donahue, R Platt

  • 1Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.

Annals of Epidemiology
|November 14, 1997
PubMed

Insights

This study found no definitive link between ibuprofen use and skin infections in children with chickenpox (varicella). Further research is needed to confirm any potential association with ibuprofen and varicella complications.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Pharmacology

Background:

  • Varicella (chickenpox) is a common childhood viral infection.
  • Dermatologic superinfections can be a complication of varicella.
  • The use of nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen during varicella has been questioned.

Purpose of the Study:

  • To investigate a potential association between ibuprofen use and the occurrence of dermatologic superinfections in children diagnosed with varicella.
  • To analyze the risk of superinfections following varicella in relation to ibuprofen exposure.

Main Methods:

  • A retrospective cohort study was conducted using health maintenance organization data.
  • Exposure was defined as dispensing of ibuprofen prior to varicella diagnosis to mitigate confounding by indication.
  • Outcomes and exposures were identified from automated medical and pharmacy records.

Main Results:

  • Among 7,013 varicella cases, 89 superinfections occurred.
  • Children with ibuprofen dispensed in the month before varicella showed a trend toward increased superinfection risk (OR 3.1, P=0.31).
  • When restricted to superinfections treated with antibiotics, the odds ratio was 5.1 (P=0.22), but not statistically significant.

Conclusions:

  • The study results are inconclusive and do not establish a clear association between ibuprofen use and dermatologic superinfections in children with varicella.
  • The findings are consistent with a wide range of effects, including no association.
  • Further research is warranted to definitively assess the relationship.
Abstract

Related Concept Videos

Chickenpox01:20

Chickenpox

Chickenpox is an acute, highly contagious disease caused by the varicella-zoster virus (VZV), a double-stranded DNA virus belonging to the Herpesviridae family. Its transmission occurs primarily through the inhalation of respiratory droplets or direct contact with vesicular fluid from skin lesions. The incubation period typically ranges from 10 to 21 days, during which the virus replicates and disseminates through sequential phases within the host. Although generally self-limiting in children,...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...